• Corporate
• Markets
• Info-Tech
• Marketing
• Money & Banking
• Agri-Biz & Commodities
• Industry & Economy
• Logistics
• Government
• Opinion
• Columns
• States
• Index

• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• Smartbuy

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

• Rates

• Ports

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Subscription

• Business Line

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

MUMBAI: Drug manufacturer Aurobindo Pharma Ltd said on Monday that it has got approval from Medicines Control Council (MCC) to manufacture and market nine products in South Africa.

Aurobindo now has a total of 31 marketing authorisations approved by MCC, it said in a statement to the BSE.

Related Stories:
Nod for APL drug
Aurobindo's ARV drug gets nod

Prev: Rupee marginally down
Next: Jai Corp Q4 net up at Rs 38.80 cr

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line